Return to homepagePandemic Pact

SIBOL Personal Protective Equipment - Design and Development of Locally-Manufactured, Reusable, Powered, Air-Purifying Respirator (PAPR)

  • Funded by Philippine Council for Health Research and Development (PCHRD)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $0

  • Funder

    Philippine Council for Health Research and Development (PCHRD)

  • Research Location

    Philippines

  • Lead Research Institution

    University of the Philippines Manila

  • Research Priority Alignment

    N/A

  • Research Category

    Infection prevention and control

  • Research Subcategory

    Barriers, PPE, environmental, animal and vector control measures

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

With the need to prevent COVID-19 transmission among healthcare workers, the SIBOL Task Force Team of UP Manila is designing and developing an innovative powered, Air-Purifying Respirator or PAPR, an additional PPE for healthcare workers to reduce their risk of contracting COVID-19 while they care for the infected patients. In 2020, the project led by Dr. Samuel Arsenio M. Grozman of UP Manila first tested the prototype for particulate air filtration standard before it was subjected to visual and communication standards. Upon completion, the project will produce a total of 20 units of prototypes for manufacturing and project commercialization. PAPR uses a pump that moves contaminated air through a filter which removes particulates through mechanical and electrostatic mechanisms. Aside from developing a PAPR that will meet the standards set by the National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), the project also aims to activate the supply chain towards the production and testing of PAPR in the country.